Merck | MRK - Ordinary Share Capital



Merck reported EUR434.78M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Adidas EUR 178.55M 451K Jun/2025
Adyen EUR 315K 4K Dec/2024
Akzo Nobel EUR 171.01M 86.01M Jun/2025
Alcon AG USD 20M 0 Mar/2025
Amadeus IT EUR 442.98M 438.48M Jun/2025
Amarin USD 308.15M 2.85M Mar/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
BASF EUR 892.52M 249.48M Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Beiersdorf EUR 220.21M 27.79M Jun/2025
Covestro EUR 188.74M 259.67K Jun/2025
Danone EUR 643.3M 473.3M Jun/2025
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
Galapagos EUR 65.9M 228.04M Jun/2025
Genmab DKK 10M 56M Mar/2025
Givaudan CHF 92M 0 Jun/2024
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Henkel EUR 413.96M 24.04M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Infineon EUR 1.3B 1.31B Jun/2025
Linde USD 468.91M 467.91M Jun/2025
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Novartis USD 793M 0 Dec/2024
Philips EUR 950.57M 762.57M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
UCB EUR 584M 0 Dec/2024